Brief: Piramal Pharma Says Successful Closure Of US FDA Inspection At Co Manufacturing Facility Located At Sellersville, USA
18/04/2023 14:55
April 18 (Reuters) - Piramal Pharma Ltd PIRM.NS :
* SUCCESSFUL CLOSURE OF US FDA INSPECTION AT CO
MANUFACTURING
FACILITY LOCATED AT SELLERSVILLE, USA
* US FDA HAS ISSUED AN ESTABLISHMENT INSPECTION REPORT FOR
THE
SAID MANUFACTURING FACILITY
Source text for Eikon: ID:nNSE5dNTWf
Further company coverage: PIRM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio